5.69 USD
-0.31 (-5.17%)
Yesterday High
$6.18
Yesterday Low
$5.90
52w High
$18.70
52w Low
$4.40
Market Cap.
$481.5M
52w Change
-51.58%
This is a preview of the full version of Prosperse
Trending News
Verve Therapeutics, Inc. is facing a class action lawsuit alleging the company made false and/or misleading statements about the circumstances under which its Heart-1 Phase 1b clinical trial of VERVE-101 would be halted, as well as overstating the potential benefits of its proprietary lipid nanopart...
Bronstein, Gewirtz & Grossman, Llc
Sep 15, 2024
Rosen Law Firm is encouraging investors of Verve Therapeutics, Inc. to seek legal counsel before the October 28, 2024 deadline in a securities class action lawsuit filed by the firm. The lawsuit alleges that Verve Therapeutics made false and/or misleading statements about the circumstances surroundi...
N/A
Sep 13, 2024
The Schall Law Firm has filed a securities fraud lawsuit against Verve Therapeutics, Inc. (VERV) for making false and misleading statements about its Heart-1 Phase 1b clinical trial and the benefits of its proprietary lipid nanoparticle (LNP) delivery system.
Prnewswire
Sep 13, 2024
Bragar Eagel & Squire, P.C. has filed class action lawsuits against WEBTOON, Verve Therapeutics, and Ardelyx, alleging that the companies made false and/or misleading statements about their business, operations, and prospects.
N/A
Sep 10, 2024
Rosen Law Firm is encouraging investors of Verve Therapeutics, Inc. to secure counsel before the October 28, 2024 lead plaintiff deadline in a securities class action lawsuit. The lawsuit alleges that Verve Therapeutics made false and/or misleading statements about the circumstances under which a cl...
N/A
Sep 9, 2024
Rosen Law Firm is encouraging investors of Verve Therapeutics, Inc. to seek legal counsel before the October 28, 2024 deadline in a securities class action lawsuit. The lawsuit alleges that Verve Therapeutics made false and misleading statements about its VERVE-101 clinical trial and the potential b...
N/A
Sep 5, 2024
Login to view more news
Dive into the world of investing with Prosperse
Explore our recent articles to learn more about how Prosperse can help you achieve your financial goals.
Read more news from Prosperse
US Stocks End Week Positively with Boost from Tech Sector and Solid Consumer Sentiment
Date: Oct 25, 2024
TSMC Achieves Higher Production Yields in Arizona Facility Compared to Taiwan
Date: Oct 25, 2024
Federal Judge Blocks Tapestry's $8.5 Billion Acquisition of Capri Holdings Due to Antitrust Concerns
Date: Oct 25, 2024
2024 Presidential Race Deadlock: Trump and Harris Tied in Pivotal Swing States
Date: Oct 24, 2024
Stocks Rebound as Tesla Leads Surge; UPS Gains Highlight Economic Trends
Date: Oct 24, 2024